Osaka, Japan

Kenji Kawada


Average Co-Inventor Count = 4.4

ph-index = 6

Forward Citations = 81(Granted Patents)


Location History:

  • Toyonaka, JP (1994 - 1997)
  • Osaka, JP (1989 - 2007)

Company Filing History:


Years Active: 1989-2007

Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovations of Kenji Kawada: A Trailblazer in Pharmaceutical Patents

Introduction

Kenji Kawada is a distinguished inventor based in Osaka, Japan, who has made significant strides in the field of pharmaceutical innovations. With a remarkable portfolio of ten patents, Kawada is recognized for his pioneering research and contributions to medicine, particularly in the design of compounds that selectively modulate immune responses.

Latest Patents

Kawada's latest patents showcase his expertise in developing compounds that target immunoglobulin E (IgE) production. His inventions include:

1. **Para-terphenyl compounds** - This invention presents a selective suppressor of IgE production. It comprises a compound that inhibits IgE production without significantly affecting the production of other antibodies such as IgG, IgM, and IgA. The compound is defined by a specific formula, where R represents hydrogen, halogen, lower alkyl, or lower alkoxy, X can be –O–, –CH–, –NR–, or –S(O)p–, and Y signifies lower alkyl or lower alkenyl. Also included is a process for producing the compound and a pharmaceutical composition containing it.

2. **P-terphenyl compounds** - Similar to his previous invention, this patent focuses on a compound that selectively suppresses IgE production. It operates through the same mechanisms and specifications in terms of the formula and compositions involved. This innovative approach presents a potential breakthrough in allergy treatments.

Career Highlights

Kenji Kawada is currently employed at Shionogi & Company Limited, a prominent player in the pharmaceutical industry known for its commitment to advancing healthcare through research and innovation. His work has established him as a key inventor within the company, contributing to the development of new therapeutic solutions.

Collaborations

Throughout his career, Kawada has collaborated with notable colleagues, including Mitsuaki Ohtani and Akinori Arimura. These partnerships have fostered a collaborative environment that stimulates the sharing of ideas and expertise, ultimately leading to enhanced innovation in their research efforts.

Conclusion

Kenji Kawada's work illustrates the vital role inventors play in advancing medicine through innovative patents. With his recent developments in selective IgE suppression, Kawada's contributions could have a lasting impact on allergy treatments and immunology. His dedication to research and collaboration underscores the importance of teamwork in the pursuit of groundbreaking inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…